A study to compare the effects and safety of 2 drugs in a disease of heart with increased pressures in lung
Phase 4
- Conditions
- Health Condition 1: null- Eisenmenger syndrome Primary pulmonary hypertension
- Registration Number
- CTRI/2017/12/010736
- Lead Sponsor
- PGIMER Chandigarh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with primary pulmonary hypertension and eisenmenger syndrome will be included
Without Comorbid hepatic or renal diseases
Exclusion Criteria
1.Secondary causes of pulmonary hypertension
2. Comorbid hepatic and renal conditions
3.Patients with coronary artery disease
4.Patients with contraindications to the drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional class (NYHA) <br/ ><br>6 min walk testTimepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method Echocardiography changes in right heart functionTimepoint: 6 weeks